A boost for US stocks amid hopes of vaccine breakthrough

THE vaccine trade is well and truly on, giving the bull market a double jolt of life and volatility.

US stocks gained last week and the Dow Jones Industrial Average completed its strongest opening in the post-World War II era after promising news emerged from a Covid-19 vaccine trial.

With more updates due from vaccine developer Moderna; the US coping with a rapidly building winter wave of novel coronavirus infections and deaths; and the possibility of another round of emergency stimulus, the coming week is sure to see major moves too.

Pfizer and its partner BioNTech as…

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

Sign UpVIEW ALL